IN THE NOW AND IN THE KNOW
verdemedica-2.jpg

LONGVIDA® CONFIRMED TO CROSS BLOOD BRAIN & BLOOD RETINAL BARRIERS

Longvida

A recent clinical publication in a peer-reviewed journal, JCI Insight, offers a practical, noninvasive approach to detect and monitor discrete retinal amyloid deposits in patients using solid-lipid curcumin and a modified scanning laser ophthalmoscope. The researchers conclude that the concept may lead to a practical and feasible approach for large-scale AD diagnosis and monitoring.2

POMELLA® : NEW RESEARCH - CARDIO-METABOLIC HEALTH

Pomella

Natural Products INSIDER, October 2016 - Researchers with the Srikot Research Institute studied the effects of Pomella® Extract (from Verdure Sciences) in patients (20-60 years of age) with myocardial infarction in conjunction with regular prescribed medications. The study determined the effects of 300 mg/Pomella twice daily for 30 days on biomedical parameters like HDL, total cholesterol, triglycerides, LDL, non-HDL cholesterol, serum homocysteine, hs-CRP, and OX-LDL as an add-on with regular medication showing improved antioxidant status of the blood biomarkers associated with cardiac health.

LONGVIDA® EXHIBITS SIGNIFICANT IMPROVEMENTS TO NEUROPROTECTIVE BIOMARKERS

Longvida, Science, Functional Food & Beverage, Dietary Supplements, Animal Health

JUNE 2017 – Researchers at Central Michigan University have taken a closer look at Longvida® Optimized Curcumin. Previously, these researchers conducted amyloid binding work in vitro with promising results1. Recently published, in the International Journal of Alzheimer’s Disease, Maiti P et al have compared standard, unformulated curcumin more closely to Longvida with SLCP™ Technology.

MELLOW YELLOW? THE MOOD AND COGNITIVE EFFECTS OF CURCUMIN FROM TURMERIC

Longvida

October 4, 2016 – Curcumin is the component of turmeric (Curcuma longa) that gives the spice its bright yellow colour. It is one of more than 5,000 flavonoids, a group of plant-based compounds thought to contribute to the health benefits of fruit and vegetables.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Please note that the physiological activity of the ingredient(s) described herein is supported by the referenced clinical trial reports. Marketers of finished products containing the ingredient(s) described herein are responsible for determining whether claims made for such products are lawful and in compliance with the laws of the country in which they will market the products.
Verdure Sciences, Longvida (US Patent 9192644, EP Patent 1993365; additional patents pending), Bacognize, Calzbone, Pomella (US Patents 7638640, 7897791, and 7919636), Tinofend, and WokVel are registered trademarks of Verdure Sciences, Inc. Ashwamax, Bacoboost, Cinnagest, Factor21, Lutevida, Maplifa, Rejuna, Thymocid, Gingerize, VBATS, VerdeMedica, and SLP/SLCP are trademarks of Verdure Sciences, Inc. All Rights Reserved. © 2017 Verdure Sciences.
For our most current patent information, please visit: www.vs-corp.com/ip